Neutralizing Antibody Response, Safety, and Efficacy of mRNA COVID-19 Vaccines in Pediatric Patients with Inflammatory Bowel Disease: A Prospective Multicenter Case—Control Study

The vaccination of immunocompromised children against coronavirus disease 2019 is an important public health issue. We evaluated the serological response, safety, and efficacy of the BNT162b2 vaccine in children with and without inflammatory bowel disease (IBD). A prospective, multicenter, case–cont...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Kyung Jae, Choi, So Yoon, Lee, Yoo Min, Kim, Han Wool
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9415578/
https://www.ncbi.nlm.nih.gov/pubmed/36016153
http://dx.doi.org/10.3390/vaccines10081265

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9415578/
https://www.ncbi.nlm.nih.gov/pubmed/36016153
http://dx.doi.org/10.3390/vaccines10081265

Ejemplares similares